Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Apr 19;18(9):pyv040.
doi: 10.1093/ijnp/pyv040.

Ketamine-Induced Modulation of the Thalamo-Cortical Network in Healthy Volunteers As a Model for Schizophrenia

Affiliations
Randomized Controlled Trial

Ketamine-Induced Modulation of the Thalamo-Cortical Network in Healthy Volunteers As a Model for Schizophrenia

Anna Höflich et al. Int J Neuropsychopharmacol. .

Abstract

Background: Schizophrenia has been associated with disturbances of thalamic functioning. In light of recent evidence suggesting a significant impact of the glutamatergic system on key symptoms of schizophrenia, we assessed whether modulation of the glutamatergic system via blockage of the N-methyl-D-aspartate (NMDA)-receptor might lead to changes of thalamic functional connectivity.

Methods: Based on the ketamine model of psychosis, we investigated changes in cortico-thalamic functional connectivity by intravenous ketamine challenge during a 55-minute resting-state scan. Thirty healthy volunteers were measured with pharmacological functional magnetic resonance imaging using a double-blind, randomized, placebo-controlled, crossover design.

Results: Functional connectivity analysis revealed significant ketamine-specific changes within the thalamus hub network, more precisely, an increase of cortico-thalamic connectivity of the somatosensory and temporal cortex.

Conclusions: Our results indicate that changes of thalamic functioning as described for schizophrenia can be partly mimicked by NMDA-receptor blockage. This adds substantial knowledge about the neurobiological mechanisms underlying the profound changes of perception and behavior during the application of NMDA-receptor antagonists.

Keywords: functional MRI; glutamate; ketamine; schizophrenia; thalamus.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Ketamine effects on functional connectivity of the thalamus hub network (analysis 1). Each period of 2.5 minutes is depicted. Interaction effects drug*time of posthoc t tests are displayed and data overlaid on a standard-MNI brain. Warm colors stand for increase of connectivity and cold colors for decreased connectivity, while color intensity refers to t-values (range t=3.09…6). A significant increase is shown in temporo-parietal regions throughout the ketamine application. x=-58mm, y=-16mm.
Figure 1.
Figure 1.
Ketamine effects on functional connectivity of the thalamus hub network (analysis 1). Each period of 2.5 minutes is depicted. Interaction effects drug*time of posthoc t tests are displayed and data overlaid on a standard-MNI brain. Warm colors stand for increase of connectivity and cold colors for decreased connectivity, while color intensity refers to t-values (range t=3.09…6). A significant increase is shown in temporo-parietal regions throughout the ketamine application. x=-58mm, y=-16mm.
Figure 2.
Figure 2.
Ketamine-induced alterations of cortic-thalamic functional connectivity (analysis 2). Posthoc t tests of the interaction drug*time show a significant increase of functional connectivity for the somatosensory (left row) and temporal cortex (right row). Other regions without significant results are not shown. Results of seed-to-voxel correlation analysis are overlaid onto a single-subject standard brain (range of t-values=3.09…6). Results are shown for each period of 2.5 minutes. z=7mm.
Figure 3.
Figure 3.
Graphical representation of study design, resting-state fMRI protocol, and the application of the study drug.

References

    1. Abel KM, Allin MP, Kucharska-Pietura K, David A, Andrew C, Williams S, Brammer MJ, Phillips ML. (2003) Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study. Neuroreport 14:387–391. - PubMed
    1. Adolphs R. (2003) Investigating the cognitive neuroscience of social behavior. Neuropsychologia 41:119–126. - PubMed
    1. Alonso-Solís A, Corripio I, de Castro-Manglano P, Duran-Sindreu S, Garcia-Garcia M, Proal E, Nuñez-Marín F, Soutullo C, Alvarez E, Gómez-Ansón B, Kelly C, Castellanos FX. (2012) Altered default network resting state functional connectivity in patients with a first episode of psychosis. Schizophr Res 139:13–18. - PMC - PubMed
    1. Anticevic A, Gancsos M, Murray JD, Repovs G, Driesen NR, Ennis DJ, Niciu MJ, Morgan PT, Surti TS, Bloch MH, Ramani R, Smith MA, Wang XJ, Krystal JH, Corlett PR. (2012) NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia. Proc Natl Acad Sci U S A 109:16720–16725. - PMC - PubMed
    1. Behrens TE, Johansen-Berg H, Woolrich MW, Smith SM, Wheeler-Kingshott CA, Boulby PA, Barker GJ, Sillery EL, Sheehan K, Ciccarelli O, Thompson AJ, Brady JM, Matthews PM. (2003) Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci 6:750–757. - PubMed

Publication types

MeSH terms

Substances